<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cancer recurrence</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Experimental vaccine aimed at improving ovarian cancer survival rates</title>
   	 <description>An experimental vaccine study currently under way at the UC Cancer Institute aims to prevent ovarian cancer recurrence by triggering the body&amp;#146;s natural defense system.</description>
     <link>http://medicalxpress.com/news/2012-03-experimental-vaccine-aimed-ovarian-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 02 Mar 2012 07:54:48 EST</pubDate>
	 <guid isPermaLink="false">news249897281</guid>
	 
</item>
<item>
     <title>Therapy targets leukemia stem cells</title>
   	 <description>New research takes aim at stubborn cancer stem cells that are thought to be responsible for treatment resistance and relapse. The study, published by Cell Press in the February 14 issue of the journal Cancer Cell, provides insight into mechanisms associated with the survival of leukemia stem cells and identifies a potential therapeutic target that is specific for these dangerously persistent cells.</description>
     <link>http://medicalxpress.com/news/2012-02-therapy-leukemia-stem-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 13 Feb 2012 14:10:01 EST</pubDate>
	 <guid isPermaLink="false">news248362666</guid>
	 
</item>
<item>
     <title>Many lung cancer patients get radiation therapy that may not prolong their lives</title>
   	 <description>A new study has found that many older lung cancer patients get treatments that may not help them live longer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that physicians should not routinely use radiation after surgery to treat lung cancer that is advanced but has not widely spread, at least in older patients.</description>
     <link>http://medicalxpress.com/news/2012-02-lung-cancer-patients-therapy-prolong.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 13 Feb 2012 03:20:03 EST</pubDate>
	 <guid isPermaLink="false">news248325587</guid>
	 
</item>
<item>
     <title>Molecular profiling reveals differences between primary and recurrent ovarian cancers</title>
   	 <description>There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling to examine the differences in the molecular characteristics of primary and recurrent ovarian tumors and found significant changes for some biomarkers. This is the first study that examined potential differences in a broad biomarker panel in patient-matched primary versus recurrent ovarian cancers and underscores the importance of analyzing the most current tumor tissue in order to make the most informed decisions about treatment for recurrence.</description>
     <link>http://medicalxpress.com/news/2012-02-molecular-profiling-reveals-differences-primary.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 10 Feb 2012 13:06:25 EST</pubDate>
	 <guid isPermaLink="false">news248101576</guid>
	 
</item>
<item>
     <title>Tapping the body's own defenses, researchers look to cutting-edge gene therapy for bladder cancer</title>
   	 <description>Bladder cancer, most frequently caused by smoking and exposure to carcinogens in the workplace, is one of the top 10 most common forms of cancer in men and women in the U.S. More than 70 percent of bladder cancers are diagnosed in stage T1 or less and have not invaded the muscle layer. At these early stages, standard treatment is surgery (transurethral resection) and the burning away of tumors with high energy electricity (fulguration). Many patients also may receive subsequent intravesical chemotherapy because there is often a high-risk for cancer recurrence.</description>
     <link>http://medicalxpress.com/news/2012-01-body-defenses-cutting-edge-gene-therapy.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 10 Jan 2012 12:17:50 EST</pubDate>
	 <guid isPermaLink="false">news245420266</guid>
	 
</item>
<item>
     <title>Downloadable tool helps cancer survivors plan and monitor exercise</title>
   	 <description>Not only is overall quality of life higher in cancer survivors who exercise, but the rate of cancer recurrence is lower. Unfortunately, though most doctors recommend exercise, many patients fail to follow through.</description>
     <link>http://medicalxpress.com/news/2012-01-downloadable-tool-cancer-survivors.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 04 Jan 2012 15:56:13 EST</pubDate>
	 <guid isPermaLink="false">news244914963</guid>
	 
</item>
<item>
     <title>Obesity linked to higher 5-year death rate after esophageal cancer surgery</title>
   	 <description>Obesity doubles the risk of cancer recurrence and cancer-related death in patients with esophageal cancer who have been treated with surgery, researchers at Mayo Clinic found. Their 778-patient study, which appeared in the Dec. 1 issue of the Journal of Clinical Oncology, found that five-year survival in obese patients -- those with a body mass index of 30 or higher -- with esophageal cancer was 18 percent, compared to 36 percent in patients of normal weight.</description>
     <link>http://medicalxpress.com/news/2011-12-obesity-linked-higher-year-death.html</link>
	 <category>Surgery</category>
	 <pubDate>Tue, 20 Dec 2011 13:16:18 EST</pubDate>
	 <guid isPermaLink="false">news243609347</guid>
	 
</item>
<item>
     <title>Researchers repair immune system in leukemia patients following chemotherapy</title>
   	 <description>A new treatment using leukemia patients' own infection-fighting cells appears to protect them from infections and cancer recurrence following treatment with fludarabine-based chemotherapy, according to new research from the Perelman School of Medicine at the University of Pennsylvania. The new process is a step toward eliminating the harsh side effects that result from the commonly prescribed drug, which improves progression-free survival in patients with chronic lymphocytic leukemia (CLL) but destroys patients' healthy immune cells in the process, leaving them vulnerable to serious viral and bacterial infections. The drug's effects on the immune system tend to be so violent that it has been dubbed &quot;AIDS in a bottle.&quot;</description>
     <link>http://medicalxpress.com/news/2011-12-immune-leukemia-patients-chemotherapy.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 12 Dec 2011 03:59:37 EST</pubDate>
	 <guid isPermaLink="false">news242884769</guid>
	 
</item>
<item>
     <title>Study: Bone drug boosts breast cancer survival</title>
   	 <description>(AP) --  Doctors were mostly hoping to prevent complications and relapses when they gave young women a medicine to keep their bones strong during breast cancer treatment. Seven years later, they found it did more than that: The bone drug improved survival, as much as many chemotherapies do.</description>
     <link>http://medicalxpress.com/news/2011-12-bone-drug-boosts-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 09 Dec 2011 03:10:01 EST</pubDate>
	 <guid isPermaLink="false">news242621950</guid>
	 
</item>
<item>
     <title>Starch intake may influence risk for breast cancer recurrence</title>
   	 <description>Researchers have linked increased starch intake to a greater risk for breast cancer recurrence, according to results presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011.</description>
     <link>http://medicalxpress.com/news/2011-12-starch-intake-breast-cancer-recurrence.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 09 Dec 2011 02:40:35 EST</pubDate>
	 <guid isPermaLink="false">news242620822</guid>
	 
</item>
<item>
     <title>Study finds side effects, complications, mastectomy more likely after partial breast irradiation</title>
   	 <description>Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate of later mastectomy, increased radiation-related toxicities and post-operative complications, compared to traditional whole breast irradiation (WBI), according to researchers from The University of Texas MD Anderson Cancer Center.</description>
     <link>http://medicalxpress.com/news/2011-12-side-effects-complications-mastectomy-partial.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 07 Dec 2011 05:00:01 EST</pubDate>
	 <guid isPermaLink="false">news242454425</guid>
	 
</item>
<item>
     <title>American Society of Clinical Oncology issues annual report on progress against cancer</title>
   	 <description>The American Society of Clinical Oncology (ASCO) today released Clinical Cancer Advances 2011: ASCO's Annual Report on Progress Against Cancer, an independent review of the advances in cancer research that have had the greatest impact on patient care this year. The report also identifies the most promising trends in oncology and provides insights from experts on where the future of cancer care is heading.</description>
     <link>http://medicalxpress.com/news/2011-12-american-society-clinical-oncology-issues.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 05 Dec 2011 16:36:10 EST</pubDate>
	 <guid isPermaLink="false">news242325328</guid>
	 
</item>
<item>
     <title>MU researchers recommend exercise for breast cancer survivors, lymphedema patients</title>
   	 <description>Lymphedema, a chronic swelling condition common in breast cancer survivors, affects three million people in the U.S. In the past, most people believed that exercise might induce or worsen lymphedema. After reviewing the literature, University of Missouri researchers say the benefits of exercise outweigh the risks for breast cancer survivors and patients with lymphedema.</description>
     <link>http://medicalxpress.com/news/2011-12-mu-breast-cancer-survivors-lymphedema.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 01 Dec 2011 12:20:05 EST</pubDate>
	 <guid isPermaLink="false">news241963590</guid>
	 
</item>
<item>
     <title>New study shows biopsy of recurrent breast cancer can alter treatment</title>
   	 <description>A second, larger clinical research study led by breast cancer specialists at Princess Margaret Hospital (PMH) has again proven that comparing a new biopsy of progressing or recurring cancer with that of the original cancer can dictate a change in treatment.</description>
     <link>http://medicalxpress.com/news/2011-11-biopsy-recurrent-breast-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 28 Nov 2011 16:00:08 EST</pubDate>
	 <guid isPermaLink="false">news241715060</guid>
	 
</item>
<item>
     <title>New target identified to stop the spread of breast cancer</title>
   	 <description>A new potential target to slow breast cancer tumor progression and metastasis has been identified by a team of researchers led by Dr. Richard Kremer from the Research Institute of the McGill University Health Centre (RI-MUHC). Complications in breast cancer patients are commonly caused by the spread of the disease through metastasis to other parts of the body, most often to the bones and lungs. These findings, published this week in the Journal of Clinical Investigation (JCI), suggest that a specific protein plays a key role in the progression of the disease outside of the initial tumor area.</description>
     <link>http://medicalxpress.com/news/2011-11-breast-cancer_1.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 10 Nov 2011 12:42:00 EST</pubDate>
	 <guid isPermaLink="false">news240151312</guid>
	 
</item>
<item>
     <title>Radiotherapy after surgery halves breast cancer recurrence</title>
   	 <description>(Medical Xpress) -- Radiotherapy following surgery for breast cancer halves the chances of the cancer coming back over the next 10 years, a study led by Oxford University researchers has found.</description>
     <link>http://medicalxpress.com/news/2011-10-radiotherapy-surgery-halves-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 20 Oct 2011 08:29:32 EST</pubDate>
	 <guid isPermaLink="false">news238318164</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/10292_breast_cancer.jpg" width="90" height="90" />
</item>
<item>
     <title>Sentinel lymph node biopsy predicts outcomes for Merkel cell carcinoma</title>
   	 <description>Patients with Merkel Cell Carcinoma who underwent a procedure called sentinel lymph node biopsy (SNLB) had a lower risk of cancer recurrence after two years, according to a study by researchers from Fox Chase Cancer Center. When the biopsy's results were used to guide subsequent tests and treatment, these patients had longer survival rates than patients who had not undergone the procedure.</description>
     <link>http://medicalxpress.com/news/2011-10-sentinel-lymph-node-biopsy-outcomes_1.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 03 Oct 2011 19:06:15 EST</pubDate>
	 <guid isPermaLink="false">news236887470</guid>
	 
</item>
<item>
     <title>Zoledronic acid reduces the recurrence of breast cancer in post-menopausal women</title>
   	 <description>A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress today. Researchers think it could be the key for a greater understanding of the mechanisms of breast cancer recurrence as well as offering new options for patient care.</description>
     <link>http://medicalxpress.com/news/2011-09-zoledronic-acid-recurrence-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 25 Sep 2011 13:28:06 EST</pubDate>
	 <guid isPermaLink="false">news236176073</guid>
	 
</item>
<item>
     <title>Radiotherapy between or during chemotherapy cycles reduces risk of breast cancer recurrence</title>
   	 <description>Stockholm, Sweden: A major UK trial has produced firm evidence that giving radiotherapy between or during chemotherapy cycles to women with early breast cancer significantly reduces the risk of the cancer recurring in the breast or chest wall. The treatment, known as synchronous chemoradiation, has minimal adverse side-effects and no detrimental effect on the patients' quality of life.</description>
     <link>http://medicalxpress.com/news/2011-09-radiotherapy-chemotherapy-breast-cancer-recurrence.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 25 Sep 2011 04:10:31 EST</pubDate>
	 <guid isPermaLink="false">news236142620</guid>
	 
</item>
<item>
     <title>Toxicity of aromatase inhibitors may explain lack of overall survival improvement</title>
   	 <description>The toxicities associated with aromatase inhibitors (AIs) may explain the lack of overall survival improvement compared with tamoxifen, according to a study published August 22 in the Journal of The National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-08-toxicity-aromatase-inhibitors-lack-survival.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 22 Aug 2011 16:26:47 EST</pubDate>
	 <guid isPermaLink="false">news233249178</guid>
	 
</item>
<item>
     <title>Mayo Clinic receives FDA approval for ovarian and breast cancer vaccines</title>
   	 <description>Mayo Clinic has received investigational new drug approval from the Food and Drug Administration for two new cancer vaccines that mobilize the body's defense mechanisms to destroy malignant cells. The vaccines are among the first aimed at preventing cancer recurrence. The approval clears the way for Phase I clinical trials with women treated for ovarian or breast cancer.</description>
     <link>http://medicalxpress.com/news/2011-08-mayo-clinic-fda-ovarian-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 17 Aug 2011 13:46:24 EST</pubDate>
	 <guid isPermaLink="false">news232807571</guid>
	 
</item>
<item>
     <title>Can gel shrink some cancer tumors?</title>
   	 <description>(Medical Xpress) -- Can a gel applied to the skin of a woman's breast provide the same cancer-fighting benefits as a pill taken by mouth but reduce the side effects of the medicine?</description>
     <link>http://medicalxpress.com/news/2011-07-gel-cancer-tumors.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 08 Jul 2011 07:47:51 EST</pubDate>
	 <guid isPermaLink="false">news229329999</guid>
	 
</item>
<item>
     <title>Can topical skin gel shrink some breast cancer tumors?</title>
   	 <description>Can a gel applied to the skin of a woman's breast provide the same cancer-fighting benefits as a pill taken by mouth but reduce the side effects of the medicine?</description>
     <link>http://medicalxpress.com/news/2011-06-topical-skin-gel-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 24 Jun 2011 10:17:15 EST</pubDate>
	 <guid isPermaLink="false">news228129398</guid>
	 
</item>
<item>
     <title>Smoking may increase risk of prostate cancer recurrence, death</title>
   	 <description>A new study from Harvard School of Public Health (HSPH) and University of California, San Francisco, researchers suggests that men with prostate cancer who smoke increase their risk of prostate cancer recurrence and of dying from the disease. A link also was found between smoking at the time of prostate cancer diagnosis and aggressive prostate cancer, overall mortality (death) and cardiovascular disease mortality.</description>
     <link>http://medicalxpress.com/news/2011-06-prostate-cancer-recurrence-death.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 21 Jun 2011 16:26:17 EST</pubDate>
	 <guid isPermaLink="false">news227892240</guid>
	 
</item>
<item>
     <title>Hypnosis/local anesthesia combination during surgery helps patients, reduces hospital stays</title>
   	 <description>Using a combination of hypnosis and local anaesthesia (LA) for certain types of surgery can aid the healing process and reduce drug use and time spent in hospital, anaesthesiologists have found. The combination could also help avoid cancer recurrence and metastases, according to new research to be presented today (Sunday) at the European Anaesthesiology Congress in Amsterdam.</description>
     <link>http://medicalxpress.com/news/2011-06-hypnosislocal-anesthesia-combination-surgery-patients.html</link>
	 <category>Other</category>
	 <pubDate>Sat, 11 Jun 2011 18:32:52 EST</pubDate>
	 <guid isPermaLink="false">news227035948</guid>
	 
</item>
<item>
     <title>DNA repair system affects colon cancer recurrence and survival</title>
   	 <description>Colorectal cancer patients with defects in mismatch repair--one of the body's systems for repairing DNA damage--have lower recurrence rates and better survival rates than patients without such defects, according to a study published online May 19th in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-05-dna-affects-colon-cancer-recurrence.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 19 May 2011 16:23:38 EST</pubDate>
	 <guid isPermaLink="false">news225040984</guid>
	 
</item>
<item>
     <title>New biomarker that predicts breast cancer relapse found</title>
   	 <description>Researchers from Virginia Commonwealth University Massey Cancer Center have discovered a new biomarker related to the body's immune system that can predict a breast cancer patients' risk of cancer recurrence. This breakthrough may lead to new genetic testing that further personalizes breast cancer care.</description>
     <link>http://medicalxpress.com/news/2011-05-biomarker-breast-cancer-relapse.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 16 May 2011 12:43:11 EST</pubDate>
	 <guid isPermaLink="false">news224768571</guid>
	 
</item>
<item>
     <title>Breast cancer multi-gene tests compared</title>
   	 <description>Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows.</description>
     <link>http://medicalxpress.com/news/2011-05-breast-cancer-multi-gene.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 05 May 2011 09:56:03 EST</pubDate>
	 <guid isPermaLink="false">news223808141</guid>
	 
</item>
<item>
     <title>MRI locates prostate cancer recurrence at extremely low PSA levels</title>
   	 <description>A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA after prostatectomy, according to a study presented April 29, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).</description>
     <link>http://medicalxpress.com/news/2011-04-mri-prostate-cancer-recurrence-extremely.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 29 Apr 2011 08:23:21 EST</pubDate>
	 <guid isPermaLink="false">news223284188</guid>
	 
</item>
<item>
     <title>ACE inhibitors may increase risk of recurrence in breast cancer survivors</title>
   	 <description>ACE inhibitors, commonly used to control high blood pressure and heart failure in women, may be associated with an increased risk of recurrence in women who have had breast cancer, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.</description>
     <link>http://medicalxpress.com/news/2011-04-ace-inhibitors-recurrence-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 20 Apr 2011 09:04:00 EST</pubDate>
	 <guid isPermaLink="false">news222509025</guid>
	 
</item>


</channel>
</rss>
